Abstract
Beginning in the mid-1970s, surgical ablation of accessory atrioventricular (AV) pathways (APs) was performed at a limited number of centers. The potential to target APs by catheter ablation became apparent in 1982, when Scheinman and coworkers introduced catheter ablation of the AV junction using high-energy direct current (DC) shocks from a defibrillator to produce AV block as palliative therapy for drug-resistant supraventricular tachyarrhythmias. Early attempts at DC shock ablation of APs were associated with some success,1 but the large area of barotrauma limited focused ablation and was associated with risk of cardiac perforation, AV block, and coronary artery injury.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
